- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del Global reconciles with shareholders
Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with
Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with interest at 6% per annum, 2.5 million shares of Del stock, and warrants to purchase one million shares exercisable at $2.00 per share, expiring in six years. The plaintiffs will also receive a $2 million cash payment to which Del will not contribute. The courts must yet approve the deal. In a separate action, Samuel E. Park has been appointed president and CEO of Del. Park has acted in this capacity since February.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
